SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-005590
Filing Date
2022-08-12
Accepted
2022-08-12 08:00:19
Documents
17
Period of Report
2022-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K xenetic_8k.htm   iXBRL 8-K 33482
2 PRESS RELEASE xenetic_ex9901.htm EX-99.1 23244
3 GRAPHIC image_001.jpg GRAPHIC 3392
4 GRAPHIC image_002.jpg GRAPHIC 3392
5 GRAPHIC image_003.jpg GRAPHIC 3392
  Complete submission text file 0001683168-22-005590.txt   294560

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE xbio-20220812.xsd EX-101.SCH 3665
7 XBRL DEFINITION FILE xbio-20220812_def.xml EX-101.DEF 26553
8 XBRL LABEL FILE xbio-20220812_lab.xml EX-101.LAB 36543
9 XBRL PRESENTATION FILE xbio-20220812_pre.xml EX-101.PRE 25177
11 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_8k_htm.xml XML 5310
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 221157871
SIC: 2834 Pharmaceutical Preparations